Efficacy of alirocumab according to background statin intensity and other lipid-lowering therapy in heterozygous familial hypercholesterolemia or high cv risk populations: phase 3 sub-group analyses
Krempf, M, Bergeron, J, Elassal, J, Minini, P, Miller, K, Kastelein, J.J.P
Published in Atherosclerosis (01.07.2015)
Published in Atherosclerosis (01.07.2015)
Get full text
Journal Article
PREVALENCE AND MANAGEMENT OF PATIENT-REPORTED SYMPTOMS ON STATIN THERAPY: INSIGHTS FROM THE PATIENT AND PROVIDER ASSESSMENT OF LIPID MANAGEMENT (PALM) REGISTRY
Boggan, Ann Marie Navar, Peterson, Eric, Li, Shuang, Wilson, Peter, Goldberg, Anne, Virani, Salim, Robinson, Jennifer, Roger, Veronique, Elassal, Joseph J, Lee, L. Veronica, Pencina, Michael, Wang, Tracy
Published in Journal of the American College of Cardiology (05.04.2016)
Published in Journal of the American College of Cardiology (05.04.2016)
Get full text
Journal Article
Concordant Loss of Imprinting of the Human Insulin-like Growth Factor II Gene Promoters in Cancer
Zhan, S, Shapiro, D, Zhan, S, Zhang, L, Hirschfeld, S, Elassal, J, Helman, L J
Published in The Journal of biological chemistry (24.11.1995)
Published in The Journal of biological chemistry (24.11.1995)
Get full text
Journal Article
Concordant loss of imprinting of the human insulin-like growth factor II gene promoters in cancer
Zhan, S, Shapiro, D, Zhang, L, Hirschfeld, S, Elassal, J, Helman, L J
Published in The Journal of biological chemistry (01.01.1995)
Get full text
Published in The Journal of biological chemistry (01.01.1995)
Journal Article